|
ZMYM3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.964900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.59690000000646E-05 |
| Normal-vs-Stage2 |
1.403210E-01 |
| Normal-vs-Stage3 |
5.879000E-01 |
| Normal-vs-Stage4 |
3.971600E-02 |
| Stage1-vs-Stage2 |
5.221400E-01 |
| Stage1-vs-Stage3 |
1.536000E-01 |
| Stage1-vs-Stage4 |
5.114800E-01 |
| Stage2-vs-Stage3 |
4.993400E-01 |
| Stage2-vs-Stage4 |
4.097000E-01 |
| Stage3-vs-Stage4 |
2.098200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.156820E-03 |
| Normal-vs-AfricanAmerican |
1.489990E-02 |
| Normal-vs-Asian |
2.300400E-02 |
| Caucasian-vs-AfricanAmerican |
9.118200E-01 |
| Caucasian-vs-Asian |
6.311800E-01 |
| AfricanAmerican-vs-Asian |
6.022400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.9124000000057E-05 |
| Normal-vs-Female |
4.962200E-01 |
| Male-vs-Female |
7.919500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.895400E-03 |
| Normal-vs-Extreme_Weight |
6.07089999999921E-05 |
| Normal-vs-Obese |
2.907200E-01 |
| Normal-vs-Extreme_Obese |
7.558600E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.745200E-01 |
| Normal_Weight-vs-Obese |
1.409570E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.251000E-01 |
| Extreme_Weight-vs-Obese |
1.134340E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.466000E-01 |
| Obese-vs-Extreme_Obese |
1.922050E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.838200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.000780E-01 |
| Normal-vs-Age(61-80Yrs) |
2.03349999999825E-05 |
| Normal-vs-Age(81-100Yrs) |
4.748000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.024200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.221900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.407250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.662300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.744770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.015800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.423000E-03 |
| Normal-VS-Type2 PRCC |
4.959300E-04 |
| Normal-VS-KIRP CIMP |
2.985900E-02 |
| Normal-VS-Unclassified PRCC |
5.321000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.216820E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.183600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.863220E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.492600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.104000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.291200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52818999999971E-05 |
| Normal-vs-N1 |
8.733400E-01 |
| Normal-vs-N2 |
6.005400E-01 |
| N0-vs-N1 |
3.790200E-02 |
| N0-vs-N2 |
1.423390E-01 |
| N1-vs-N2 |
8.820800E-01 |
|
|
